Sign In
Buy CODX
$1.44
-0.120 (-7.69%)
At Close: Jul 31, 2026
Establishment Labs (NASDAQ:ESTA) vs. Co-Diagnostics (NASDAQ:CODX) Head to Head Contrast
03:29am, Thursday, 19'th Feb 2026
Co-Diagnostics (NASDAQ: CODX - Get Free Report) and Establishment Labs (NASDAQ: ESTA - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies
Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai
09:00am, Monday, 09'th Feb 2026
SALT LAKE CITY, Feb. 9, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (OTC: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of mole
Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument
09:00am, Thursday, 05'th Feb 2026
CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or distribution SALT LAKE CITY, Feb. 5, 2026 /PRNewswire/ -- Co-Diagnostics, Inc.
Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform
09:00am, Wednesday, 04'th Feb 2026
Company and CoSara believe that ISO certification is a critical component of the regulatory requirements for clearance of new platform SALT LAKE CITY, Feb. 4, 2026 /PRNewswire/ -- Co-Diagnostics, Inc
Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships
09:00am, Monday, 12'th Jan 2026
SALT LAKE CITY, Jan. 12, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development o
CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform
11:50am, Wednesday, 31'st Dec 2025
CoDiagnostics secures its first patent for the Co-Dx PCR platform in Australia, strengthening IP protection as the point-of-care system awaits regulatory clearance.
Co-Diagnostics Announces Reverse Stock Split
09:00am, Tuesday, 30'th Dec 2025
SALT LAKE CITY, Dec. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies
09:00am, Monday, 29'th Dec 2025
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the
Short Interest in Co-Diagnostics, Inc. (NASDAQ:CODX) Drops By 43.3%
04:20am, Saturday, 27'th Dec 2025
Co-Diagnostics, Inc. (NASDAQ: CODX - Get Free Report) was the target of a significant decline in short interest during the month of December. As of December 15th, there was short interest totaling 646
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
09:00am, Thursday, 18'th Dec 2025
SALT LAKE CITY , Dec. 18, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development o
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation
09:00am, Wednesday, 17'th Dec 2025
SALT LAKE CITY , Dec. 17, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of m
CarePayment Technologies (OTCMKTS:CPYT) & Co-Diagnostics (NASDAQ:CODX) Head to Head Survey
03:54am, Tuesday, 16'th Dec 2025
CarePayment Technologies (OTCMKTS:CPYT - Get Free Report) and Co-Diagnostics (NASDAQ: CODX - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two c
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025
09:00am, Tuesday, 09'th Dec 2025
SALT LAKE CITY , Dec. 9, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of m
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
12:36pm, Monday, 08'th Dec 2025
Ongoing Phase II preclinical study data for Co-Dx PCR MTB and HPV tests support advancement to clinical performance testing SALT LAKE CITY , Dec. 9, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasda
CoDiagnostics (CODX) Upgraded to Buy: Here's What You Should Know
01:01pm, Tuesday, 02'nd Dec 2025
CoDiagnostics (CODX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
